Skip to main content
ZYBT logo
ZYBT
(NASDAQ)
Zhengye Biotechnology Holding Limited
$1.80-- (--)
Loading... - Market loading

Zhengye Biotechnology Holding (ZYBT) Company Profile

Complete business overview, executive team, trading details, and corporate information.

Zhengye Biotechnology Holding Limited
ZYBTNasdaq Stock MarketHealthcareDrug Manufacturers - Specialty & Generic

About Zhengye Biotechnology Holding

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People’s Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Stock Details

ExchangeNasdaq Stock Market (NASDAQ)
CurrencyUSD - USD
TypeStock
Share ClassClass A Shares

Contact Information

Phone86 432 6304 7008
Address
No.1 Lianmeng Road, Jilin Economic & Technical Development Zone Jilin China

Corporate Identifiers

CIK0001975641
CUSIPG989MS101
ISINKYG989MS1016
SIC2834

Leadership Team & Key Executives

Aiden Han
Co-Chief Executive Officer
Songlin Song
Co-Chief Executive Officer
Ping Wang
Chief Financial Officer
Zhongyao Liu
Chief Operating Officer
Yuhong Cheng
Vice General Manager